Abstract

GLOECK, N; JACA, A; KREDO, T  and  CALLIGARO, G. Cochrane Corner: The use of anticoagulants in patients hospitalised with COVID-19. South. Afr. j. crit. care (Online) [online]. 2023, vol.39, n.2, pp.54-56. ISSN 2078-676X.  http://dx.doi.org/10.7196/SAJCC.2023.v39i2.450.

In this Cochrane Corner, we highlight the main findings of a Cochrane Review by Flumignan et al. entitled 'Anticoagulants for people hospitalised with COVID-19' and discuss the implications of these findings for research and practice in South Africa. In particular, we underscore the need for additional, high-quality, randomised controlled trials comparing different intensities of anticoagulation in patients with COVID-19 illness. Individuals in the intensive care unit and those hospitalised with another illness who are incidentally found to be infected with SARS-CoV-2 should still only be treated with prophylactic-dose low-molecular-weight heparin.

        · text in English     · English ( pdf )